z-logo
open-access-imgOpen Access
Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82
Author(s) -
Masafumi Takeda,
Yasuharu Kanki,
Hidetoshi Masumoto,
Shunsuke Funakoshi,
Takeshi Hatani,
Hiroyuki Fukushima,
Akashi Izumi-Taguchi,
Yusuke Matsui,
Teppei Shimamura,
Yoshinori Yoshida,
Jun K. Yamashita
Publication year - 2018
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2017.12.057
Subject(s) - microbiology and biotechnology , biology , induced pluripotent stem cell , wnt signaling pathway , mesoderm , tetraspanin , progenitor cell , regeneration (biology) , stem cell , embryonic stem cell , cell , signal transduction , genetics , gene
Here, we find that human-induced pluripotent stem cell (hiPSC)-derived cardiomyocyte (CM)-fated progenitors (CFPs) that express a tetraspanin family glycoprotein, CD82, almost exclusively differentiate into CMs both in vitro and in vivo. CD82 is transiently expressed in late-stage mesoderm cells during hiPSC differentiation. Purified CD82 + cells gave rise to CMs under nonspecific in vitro culture conditions with serum, as well as in vivo after transplantation to the subrenal space or injured hearts in mice, indicating that CD82 successfully marks CFPs. CD82 overexpression in mesoderm cells as well as in undifferentiated hiPSCs increased the secretion of exosomes containing β-catenin and reduced nuclear β-catenin protein, suggesting that CD82 is involved in fated restriction to CMs through Wnt signaling inhibition. This study may contribute to the understanding of CM differentiation mechanisms and to cardiac regeneration strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom